Resources
Resources for Patients
Today young adult survivors of cancer and other diseases are looking forward to a future of long term survival due to improved treatments. However, many of the therapies that have so effectively helped increase survival have side effects that may cause the loss of fertility. New reproductive technologies are providing possibilities for preserving fertility in survivors of cancer and other diseases, yet many patients are unaware of these options.
Today young adult survivors of cancer and other diseases are looking forward to a future of long term survival due to improved treatments. However, many of the therapies that have so effectively helped increase survival have side effects that may cause the loss of fertility. New reproductive technologies are providing possibilities for preserving fertility in survivors of cancer and other diseases, yet many patients are unaware of these options.
Resources For Health Care Professionals
The Oncofertility Consortium encourages collaboration between oncologists, reproductive endocrinologists and other healthcare professionals to develop opportunities for training new oncofertility scholars who can bridge the gap between these disciplines and effectively communicate fertility-preservation options to patients at the time of their diagnosis, before treatment begins.
The Oncofertility Consortium encourages collaboration between oncologists, reproductive endocrinologists and other healthcare professionals to develop opportunities for training new oncofertility scholars who can bridge the gap between these disciplines and effectively communicate fertility-preservation options to patients at the time of their diagnosis, before treatment begins.
Resources for Researchers
The Oncofertility Consortium has made instrumental basic science breakthroughs in follicle biology, and ongoing efforts are underway to translate these successes into clinical practice. We developed a novel alginate hydrogel-based in vitro follicle culture system that maintains the follicle’s three-dimensional architecture as it grows. This culture system, which was first optimized in a mouse model system, results in fertilization-competent female gametes that are capable of giving rise to live offspring.
The Oncofertility Consortium has made instrumental basic science breakthroughs in follicle biology, and ongoing efforts are underway to translate these successes into clinical practice. We developed a novel alginate hydrogel-based in vitro follicle culture system that maintains the follicle’s three-dimensional architecture as it grows. This culture system, which was first optimized in a mouse model system, results in fertilization-competent female gametes that are capable of giving rise to live offspring.
Resources for Educators
Educators play an important role in the Oncofertility Consortium’s mission. A solid understanding of reproductive biology is important to ensure that all people can make fully informed decisions about their future reproductive health. Thus, public education is a critical function to disseminate information to male and female patients, their partners, and their parents.
Educators play an important role in the Oncofertility Consortium’s mission. A solid understanding of reproductive biology is important to ensure that all people can make fully informed decisions about their future reproductive health. Thus, public education is a critical function to disseminate information to male and female patients, their partners, and their parents.